
Journal of Medicinal Chemistry p. 260 - 267 (1994)
Update date:2022-08-05
Topics:
Reddy, N. Laxma
Hu, Lain-Yen
Cotter, Ronald E.
Fischer, James B.
Wong, Wen Jee
et al.
Diarylguanidines, acting as NMDA receptor ion channel site ligands, represent a new class of potential neuroprotective drugs.Several diarylguanidines structurally related to N,N'-di-o-tolylguanidine (DTG), a known selective ? receptor ligand, were synthes
View MoreShenyang NovPharm Technology Co., Ltd.
Contact:.+86-24-24165786
Address:Room 306, Hongjin Mansion, No. 36-1, Wanliutang Rd., Shenhe District, Shenyang, Liaoning, P.R.C.
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Contact:+86-577-65618087-605
Address:Room 402, Unit 4 Xinhu Bldg. Waitan Ruian City, Zhejiang China.
Hangzhou J&H Chemical Co., Ltd.
website:http://www.jhechem.com/
Contact:+86-571-87396432
Address:No.200 Zhenhua Rd.Xihu Industrial Park, Hangzhou 310030, China
QINGDAO NEW FLOURISH INTERNATIOANAL TRADE CO., LTD.
Contact:+86 532 80861829
Address:No. 1, Yinchuan East Road, 266061, Qingdao, China
Doi:10.1007/BF00515428
(1986)Doi:10.1021/ol101147b
(2010)Doi:10.1016/0022-328X(86)84037-2
(1986)Doi:10.1016/j.tetasy.2008.05.024
(2008)Doi:10.1016/S0040-4020(99)00996-5
(1999)Doi:10.1128/AAC.01326-07
(2008)